Boston Scientific Corp
NYSE:BSX
Boston Scientific Corp
NYSE:BSX
Price:
72.545 USD
-0.42%
Updated:
May 6, 2024
Boston Scientific Corp
Cash from Operating Activities
|
Boston Scientific Corp
Cash from Operating Activities Peer Comparison
Comparables:
BDX
EW
SYK
ABT
ISRG
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Boston Scientific Corp
NYSE:BSX
|
Cash from Operating Activities
$2.5B
|
CAGR 3-Years
10%
|
CAGR 5-Years
40%
|
CAGR 10-Years
8%
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Cash from Operating Activities
$3.4B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
4%
|
CAGR 10-Years
8%
|
|
|
Edwards Lifesciences Corp
NYSE:EW
|
Cash from Operating Activities
$895.8m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
3%
|
CAGR 10-Years
6%
|
|
|
Stryker Corp
NYSE:SYK
|
Cash from Operating Activities
$3.5B
|
CAGR 3-Years
3%
|
CAGR 5-Years
6%
|
CAGR 10-Years
6%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Cash from Operating Activities
$7.3B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
4%
|
CAGR 10-Years
9%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Cash from Operating Activities
$1.7B
|
CAGR 3-Years
2%
|
CAGR 5-Years
7%
|
CAGR 10-Years
8%
|
See Also
What is Boston Scientific Corp's Cash from Operating Activities?
Cash from Operating Activities
2.5B
USD
2.5B
USD
Based on the financial report for Mar 31, 2024, Boston Scientific Corp's Cash from Operating Activities amounts to 2.5B USD.
What is Boston Scientific Corp's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
8%
8%
Over the last year, the Cash from Operating Activities growth was 41%. The average annual Cash from Operating Activities growth rates for Boston Scientific Corp have been 10% over the past three years , 40% over the past five years , and 8% over the past ten years .
You don't have any saved screeners yet
